Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system
- PMID: 16893422
- DOI: 10.1111/j.1471-4159.2006.03928.x
Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system
Abstract
Neural apoptosis-regulated convertase-1/proprotein convertase subtilisin-kexin like-9 (NARC-1/PCSK9) is a proprotein convertase recently described to play a major role in cholesterol homeostasis through enhanced degradation of the low-density lipoprotein receptor (LDLR) and possibly in neural development. Herein, we investigated the potential involvement of this proteinase in the development of the CNS using mouse embryonal pluripotent P19 cells and the zebrafish as models. Time course quantitative RT-PCR analyses were performed following retinoic acid (RA)-induced neuroectodermal differentiation of P19 cells. Accordingly, the mRNA levels of NARC-1/PCSK9 peaked at day 2 of differentiation and fell off thereafter. In contrast, the expression of the proprotein convertases subtilisin kexin isozyme 1/site 1 protease and Furin was unaffected by RA, whereas that of PC5/6 and PC2 increased within and/or after the first 4 days of the differentiation period respectively. This pattern was not affected by the cholesterogenic transcription factor sterol regulatory element-binding protein-2, which normally up-regulates NARC-1/PCSK9 mRNA levels in liver. Furthermore, in P19 cells, RA treatment did not affect the protein level of the endogenous LDLR. This agrees with the unique expression pattern of NARC-1/PCSK9 in the rodent CNS, including the cerebellum, where the LDLR is not significantly expressed. Whole-mount in situ hybridization revealed that the pattern of expression of zebrafish NARC-1/PCSK9 is similar to that of mouse both in the CNS and periphery. Specific knockdown of zebrafish NARC-1/PCSK9 mRNA resulted in a general disorganization of cerebellar neurons and loss of hindbrain-midbrain boundaries, leading to embryonic death at approximately 96 h after fertilization. These data support a novel role for NARC-1/PCSK9 in CNS development, distinct from that in cholesterogenic organs such as liver.
Similar articles
-
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1454-9. doi: 10.1161/01.ATV.0000134621.14315.43. Epub 2004 Jun 3. Arterioscler Thromb Vasc Biol. 2004. PMID: 15178557
-
Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1171-8. doi: 10.1161/ATVBAHA.113.302670. Epub 2014 Mar 27. Arterioscler Thromb Vasc Biol. 2014. PMID: 24675665
-
Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.Hepatology. 2008 Aug;48(2):646-54. doi: 10.1002/hep.22354. Hepatology. 2008. PMID: 18666258
-
The proprotein convertases are potential targets in the treatment of dyslipidemia.J Mol Med (Berl). 2007 Jul;85(7):685-96. doi: 10.1007/s00109-007-0172-7. Epub 2007 Mar 10. J Mol Med (Berl). 2007. PMID: 17351764 Review.
-
The proprotein convertases and their implication in sterol and/or lipid metabolism.Biol Chem. 2006 Jul;387(7):871-7. doi: 10.1515/BC.2006.110. Biol Chem. 2006. PMID: 16913836 Review.
Cited by
-
Increased serum PCSK9 in patients with idiopathic pulmonary arterial hypertension: insights from inflammatory cytokines.Pulm Circ. 2021 Oct 12;11(4):20458940211051292. doi: 10.1177/20458940211051292. eCollection 2021 Oct-Dec. Pulm Circ. 2021. PMID: 34659741 Free PMC article.
-
Evolocumab attenuates myocardial ischemia/reperfusion injury by blocking PCSK9/LIAS-mediated cuproptosis of cardiomyocytes.Basic Res Cardiol. 2025 Apr;120(2):301-320. doi: 10.1007/s00395-025-01100-5. Epub 2025 Feb 11. Basic Res Cardiol. 2025. PMID: 39930254
-
Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9.Int J Biomed Investig. 2020 Jan-Jun;3(1):123. doi: 10.31531/2581-4745.1000123. Epub 2020 Feb 27. Int J Biomed Investig. 2020. PMID: 32587953 Free PMC article.
-
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's Disease.Front Aging Neurosci. 2019 May 22;11:120. doi: 10.3389/fnagi.2019.00120. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31178716 Free PMC article.
-
PCSK9: From Basic Science Discoveries to Clinical Trials.Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227. Circ Res. 2018. PMID: 29748367 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous